Anthrax lethal factor is a mapk kinase protease

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/37 (2006.01) G06F 19/00 (2006.01)

Patent

CA 2324379

The present invention relates to in vitro and ex vivo methods of screening for modulators, homologues, and mimetics of lethal factor mitogen activated protein kinase kinase (MAPKK) protease activity, as well as methods of treating cancer by administering LF to transformed cells.

La présente invention concerne des procédés permettant de rechercher systématiquement, in vitro comme ex vivo, des modulateurs, des homologues et des mimétiques de l'activité protéasique de la MAPKK (mitogen activated protein kinase kinase) du facteur létal, c'est-à-dire la kinase de protéine kinase activée par les mitonnes du facteur létal. L'invention concerne également une thérapie anticancéreuse consistant en l'administration de facteur létal à des cellules transformées.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anthrax lethal factor is a mapk kinase protease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anthrax lethal factor is a mapk kinase protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthrax lethal factor is a mapk kinase protease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1596116

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.